PL332771A1 - Derivatives of benzoxazoles exhibiting affinity to bonding locations of amino acid receptors - Google Patents
Derivatives of benzoxazoles exhibiting affinity to bonding locations of amino acid receptorsInfo
- Publication number
- PL332771A1 PL332771A1 PL97332771A PL33277197A PL332771A1 PL 332771 A1 PL332771 A1 PL 332771A1 PL 97332771 A PL97332771 A PL 97332771A PL 33277197 A PL33277197 A PL 33277197A PL 332771 A1 PL332771 A1 PL 332771A1
- Authority
- PL
- Poland
- Prior art keywords
- benzoxazoles
- derivatives
- amino acid
- acid receptors
- bonding locations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19643790A DE19643790A1 (de) | 1996-10-30 | 1996-10-30 | Benzoxazol-Derivat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL332771A1 true PL332771A1 (en) | 1999-10-11 |
Family
ID=7809592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97332771A PL332771A1 (en) | 1996-10-30 | 1997-10-10 | Derivatives of benzoxazoles exhibiting affinity to bonding locations of amino acid receptors |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0938485A1 (xx) |
| JP (1) | JP2001502713A (xx) |
| KR (1) | KR20000052876A (xx) |
| CN (1) | CN1235604A (xx) |
| AR (1) | AR008512A1 (xx) |
| AU (1) | AU4946597A (xx) |
| BR (1) | BR9712577A (xx) |
| CA (1) | CA2270359A1 (xx) |
| CZ (1) | CZ147999A3 (xx) |
| DE (1) | DE19643790A1 (xx) |
| HU (1) | HUP9904547A3 (xx) |
| NO (1) | NO992063L (xx) |
| PL (1) | PL332771A1 (xx) |
| SK (1) | SK53699A3 (xx) |
| WO (1) | WO1998018793A1 (xx) |
| ZA (1) | ZA979725B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9725541D0 (en) * | 1997-12-02 | 1998-02-04 | Pharmacia & Upjohn Spa | Amino-benzothiazole derivatives |
| DE19812331A1 (de) * | 1998-03-20 | 1999-09-23 | Merck Patent Gmbh | Piperidinderivate |
| PE20000728A1 (es) | 1998-06-26 | 2000-08-21 | Cocensys Inc | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda |
| US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| EP1674087A1 (en) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
| DE10120159A1 (de) * | 2001-04-25 | 2002-10-31 | Merck Patent Gmbh | NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen |
| ATE408611T1 (de) | 2001-07-24 | 2008-10-15 | Richter Gedeon Nyrt | Piperidine als nmda-rezeptorantagonisten |
| DE102007047737A1 (de) * | 2007-10-05 | 2009-04-30 | Merck Patent Gmbh | Piperidin- und Piperazinderivate |
| DE102009049211A1 (de) | 2009-10-13 | 2011-04-28 | Merck Patent Gmbh | Sulfoxide |
| SG11201402472QA (en) | 2011-11-22 | 2014-06-27 | Univ California | Cysteamine and/or cystamine for treating ischemic injury |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE174915T1 (de) * | 1994-10-31 | 1999-01-15 | Merck Patent Gmbh | Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren |
-
1996
- 1996-10-30 DE DE19643790A patent/DE19643790A1/de not_active Withdrawn
-
1997
- 1997-10-10 CN CN97199279A patent/CN1235604A/zh active Pending
- 1997-10-10 KR KR1019990703727A patent/KR20000052876A/ko not_active Application Discontinuation
- 1997-10-10 CA CA002270359A patent/CA2270359A1/en not_active Abandoned
- 1997-10-10 JP JP10519971A patent/JP2001502713A/ja active Pending
- 1997-10-10 PL PL97332771A patent/PL332771A1/xx unknown
- 1997-10-10 BR BR9712577-6A patent/BR9712577A/pt not_active Application Discontinuation
- 1997-10-10 CZ CZ991479A patent/CZ147999A3/cs unknown
- 1997-10-10 SK SK536-99A patent/SK53699A3/sk unknown
- 1997-10-10 WO PCT/EP1997/005590 patent/WO1998018793A1/de not_active Application Discontinuation
- 1997-10-10 EP EP97912162A patent/EP0938485A1/de not_active Withdrawn
- 1997-10-10 AU AU49465/97A patent/AU4946597A/en not_active Abandoned
- 1997-10-10 HU HU9904547A patent/HUP9904547A3/hu unknown
- 1997-10-29 ZA ZA9709725A patent/ZA979725B/xx unknown
- 1997-10-29 AR ARP970105012A patent/AR008512A1/es unknown
-
1999
- 1999-04-29 NO NO992063A patent/NO992063L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2270359A1 (en) | 1998-05-07 |
| WO1998018793A1 (de) | 1998-05-07 |
| JP2001502713A (ja) | 2001-02-27 |
| HUP9904547A3 (en) | 2001-01-29 |
| NO992063D0 (no) | 1999-04-29 |
| AU4946597A (en) | 1998-05-22 |
| CZ147999A3 (cs) | 1999-08-11 |
| SK53699A3 (en) | 2000-03-13 |
| HUP9904547A2 (hu) | 2000-12-28 |
| ZA979725B (en) | 1998-05-22 |
| NO992063L (no) | 1999-04-29 |
| AR008512A1 (es) | 2000-01-19 |
| CN1235604A (zh) | 1999-11-17 |
| EP0938485A1 (de) | 1999-09-01 |
| DE19643790A1 (de) | 1998-05-07 |
| BR9712577A (pt) | 1999-10-19 |
| KR20000052876A (ko) | 2000-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL337773A1 (en) | Derivatives of benzimidazoles | |
| PL329125A1 (en) | Novel application of n-(phosphonomethyl) glycin and derivatives thereof | |
| PL340285A1 (en) | Cyclic amino acids and their derivatives useful as pharmacological agents | |
| HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
| PL327177A1 (en) | Derivatives of 3-pyrazole carboxyamide exhibiting affinity to canabinoidic receptor | |
| PL339660A1 (en) | Derivatives of amidocarboxylic acids | |
| PL330482A1 (en) | Novel amino acid derivatives and their application as thrombosin inhibitors | |
| PL338144A1 (en) | Derivatives of dolastatin 15 | |
| HUP9801838A3 (en) | Indole derivatives as antagonists of excitatory amino acids | |
| PL339559A1 (en) | Mcp-2 trimmed at their amino end as antagosists of chemokin | |
| PL336502A1 (en) | Derivatives of ergoline and their application as antagonists of somatostatin receptors | |
| PL332771A1 (en) | Derivatives of benzoxazoles exhibiting affinity to bonding locations of amino acid receptors | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| PL311266A1 (en) | Application of indole derivatives as 5ht1 antagonists | |
| PL326072A1 (en) | Agonists of haemopoietic multifunctional receptors | |
| PL340411A1 (en) | Receptor with affinity in respect to compounds of oxazoline class | |
| PL341221A1 (en) | Derivatives of phenylaminoalkyl carboxylic acid and pharmacological compositions containing them | |
| HK1028561A1 (en) | Pharmaceutical composition for reducing production of mcp-1 protein | |
| PL330708A1 (en) | Derivatives of indolydine useful as antagonists of 5-ht-2c receptor | |
| SG71785A1 (en) | Deploymerization of polyamides | |
| DE69513832D1 (de) | Exzitatorische aminosäure-rezeptor-antagonisten | |
| PL322721A1 (en) | Derivatives of benzimidazole | |
| ZA895000B (en) | Ethereal n-terminal aminodiol amino acid derivatives as anti-hypertensive agents | |
| ID24267A (id) | Enansiomer-enansiomer dari 4-[[(sianoimino) [(1,2,2-trimetilpropil) amino] metil] amino] benzonitril | |
| PL317853A1 (en) | Derivatives of amino acids |